APA (7th ed.) Citation

M, R., J, F., T, J., Z, L., P, G., L, J., . . . M, V. (2026). RMC-6272, a selective third-generation bi-steric mTORC1 inhibitor, improves cardiac function in pressure overload-induced cardiac hypertrophy. Journal of molecular and cellular cardiology plus, 16, 100847. https://doi.org/10.1016/j.jmccpl.2026.100847

Chicago Style (17th ed.) Citation

M, Rogge, Fischer J, Jakobi T, Loewenthal Z, Gupta P, Jürgensen L, Frey N, Sandmann C, and Völkers M. "RMC-6272, a Selective Third-generation Bi-steric MTORC1 Inhibitor, Improves Cardiac Function in Pressure Overload-induced Cardiac Hypertrophy." Journal of Molecular and Cellular Cardiology Plus 16 (2026): 100847. https://doi.org/10.1016/j.jmccpl.2026.100847.

MLA (9th ed.) Citation

M, Rogge, et al. "RMC-6272, a Selective Third-generation Bi-steric MTORC1 Inhibitor, Improves Cardiac Function in Pressure Overload-induced Cardiac Hypertrophy." Journal of Molecular and Cellular Cardiology Plus, vol. 16, 2026, p. 100847, https://doi.org/10.1016/j.jmccpl.2026.100847.